|[January 18, 2013]
Research and Markets: Cardiovascular Risk Factors - Pipeline Review, H2 2012 Out Now
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/kxkf6s/cardiovascular)
has announced the addition of Global Markets Direct's new report
"Cardiovascular Risk Factors - Pipeline Review, H2 2012" to their
Global Markets Direct's, 'Cardiovascular Risk Factors - Pipeline Review,
H2 2012', provides an overview of the indication's therapeutic pipeline.
This report provides information on the therapeutic development for
Cardiovascular Risk Factors, complete with latest updates, and special
features on late-stage and discontinued projects. It also reviews key
players involved in the therapeutic developmen for Cardiovascular Risk
Factors. Cardiovascular Risk Factors - Pipeline Review, Half Year is
built using data and information sourced from Global Markets Direct's
proprietary databases, Company/University websites, SEC (News - Alert) filings,
investor presentations and featured press releases from
company/university sites and industry-specific third party sources, put
together by Global Markets Direct's team.
- A snapshot of the global therapeutic scenario for Cardiovascular Risk
- A review of the Cardiovascular Risk Factors products under development
by companies and universities/research institutes based on information
derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging
from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and
- Coverage of the Cardiovascular Risk Factors pipeline on the basis of
route of administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.
For more information visit http://www.researchandmarkets.com/research/kxkf6s/cardiovascular
Source (News - Alert): Global Markets Direct
[ Back To Technology News's Homepage ]